[Evolution of iodine uptake, PBI-131, PBI-127 and clinical symptoms following administration of triiodothyronine to subjects with hyperthyroidism caused by diffuse thyroid hyperplasia. Role of the lymphatic system and LATS in the effect of Graves disease stimulation].
D000368:Aged; D001798:Blood Proteins; D006111:Graves Disease / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007455:Iodine / Q000097:blood* / Q000378:metabolism; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator / Q000502:physiology; D008208:Lymphatic System / Q000276:immunology; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D011485:Protein Binding; D011877:Radionuclide Imaging; D013960:Thyroid Function Tests; D014284:Triiodothyronine
D001798:Blood Proteins; D007093:Imidazoles; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D008713:Methimazole; D008135:Long-Acting Thyroid Stimulator; D007455:Iodine
Evolution de la captation eodée, du PBI-131, PBI-127 et des symptômes cliniques lors de l'administration de triiodothyronine à des hyperthyroïdienne diffuse. Rôle de l'appareil lymphoïde et du LATS dans l'effet de stimulation basedowienne.